Zobrazeno 1 - 10
of 195
pro vyhledávání: '"Eric Thervet"'
Autor:
Nolwenn Rabot, Xavier Puéchal, E Cornec-Le Gall, C. Levi, A. Karras, Albertine Aouba, R. Philip, A Huart, M. Touzot, Vincent Audard, M. Clerte, Eric Thervet
Publikováno v:
Scandinavian Journal of Rheumatology. 51:205-213
Objective: Double-positive patients (DPPs), combining serum and/or histological findings for glomerular basement membrane (GBM) disease and anti-neutrophil cytoplasmic antibodies (ANCAs), are rare and poorly described. This study aimed to compare cha
Autor:
Emmanuel Lafont, Hélène Pere, David Lebeaux, Geoffrey Cheminet, Eric Thervet, Romain Guillemain, Adrien Flahault
Publikováno v:
The Journal of antimicrobial chemotherapy. 77(10)
Background Little is known about targeted (antiviral or monoclonal antibody) anti-SARS-CoV-2 treatment in immunocompromised patients with COVID-19. Objectives To assess the real-life efficacy and tolerance of targeted treatment of COVID-19 in immunoc
Autor:
Yann Nguyen, Adrien Flahault, Nathalie Chavarot, Cléa Melenotte, Morgane Cheminant, Paul Deschamps, Nicolas Carlier, Emmanuel Lafont, Marion Thomas, Edouard Flamarion, David Lebeaux, Caroline Charlier, Anne Rachline, Corinne Guérin, Robert Ratiney, Justine Touchard, Hélène Péré, Flore Rozenberg, Fanny Lanternier, Jean-Benoît Arlet, Jérôme Avouac, Véronique Boussaud, Romain Guillemain, Marguerite Vignon, Eric Thervet, Anne Scemla, Laurence Weiss, Luc Mouthon
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 28(12)
Immunocompromised patients have an increased risk of a severe form of COVID-19. The clinical efficacy of the tixagevimab/cilgavimab monoclonal antibody combination as pre-exposure prophylaxis against BA.1 and BA.2 SARS-CoV-2 Omicron sublineages is un
Autor:
Hélène Lazareth, Frédéric Capuano, Sophie Calmus, Marie Erbault, Sandrine Morin, Eric Thervet, Laetitia May‐Michelangeli, Catherine Grenier
Publikováno v:
Seminars in dialysisREFERENCES. 35(6)
End stage kidney disease (ESKD) is associated with increased morbidity and mortality. Hemodialysis (HD) is the main technique used for kidney replacement therapy. Dialyzed patients are expected to live less than one half as long as their counterparts
Autor:
Adrien Flahault, Justine Touchard, Hélène Péré, Laetitia Ulrich, Brigitte Sabatier, David Veyer, David Lebeaux, Eric Thervet
Publikováno v:
Kidney international. 101(4)
Autor:
Ferielle Louillet, Guillaume Mestrallet, Aram G. Gyulkhandanyan, Amélie Ryckewaert, Bruno O. Villoutreix, Véronique Frémeaux-Bacchi, Magali Devriese, Paula Vieira Martins, Olivia Boyer, Caroline Rousset-Rouvière, Elodie Merieau, Morgane Mignotet, Lubka T. Roumenina, Tania Robe-Rybkine, Eric Thervet, Maria A. Miteva, Sophie Chauvet, J. Hogan, Tim Ulinski, Romain Berthaud
Publikováno v:
J Am Soc Nephrol
Background The pathophysiology of the leading cause of pediatric acute nephritis, acute postinfectious GN, including mechanisms of the pathognomonic transient complement activation, remains uncertain. It shares clinicopathologic features with C3 glom
Publikováno v:
Nephrology Dialysis Transplantation. 36:1799-1802
Autor:
Stanislas Faguer, Noémie Le Gouellec, François Maurier, Bertrand Lioger, Patrice Cacoub, Noémie Jourde-Chiche, Sébastien Sanges, Christian Lavigne, Benjamin Terrier, Julie Goutte, Geoffrey Urbanski, Zahir Amoura, Aurélie Hummel, Evangeline Pillebout, Sophie Deriaz, Loic Raffray, Alban Deroux, Alexandra Audemard-Verger, Elisabeth Diot, Guillaume Moulis, Nicole Feirreira-Maldent, Johan Chanal, François Maillot, A. Baldolli, Loïc Guillevin, Jean-François Augusto, Eric Thervet
Publikováno v:
Rheumatology
Rheumatology, 2021, 60 (9), pp.4245-4251. ⟨10.1093/rheumatology/keaa921⟩
Rheumatology, 2021, 60 (9), pp.4245-4251. ⟨10.1093/rheumatology/keaa921⟩
Objectives Immunoglobulin A vasculitis (IgAV) is a small-vessel vasculitis most frequently benign in children while more severe in adults. We aimed to study the impact of age on presentation and outcome of adult IgAV. Methods We conducted a nationwid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a975c5aa180343bbcd8a462e2c0813db
https://hal.inrae.fr/hal-03775149
https://hal.inrae.fr/hal-03775149
Autor:
Marie Courbebaisse, Elise Mercadier-Riaz, Eric Thervet, Nicolas Delanoy, Nicolas Pallet, Raphae¨l Cohen, Pierre Combe, Hamza Ayari, Emilie Boissier, Hélène Lazareth, Céline Crespel, Alexandre Karras
Publikováno v:
American Journal of Kidney Diseases. 76:898-900
Autor:
Sophie Chauvet, Jill J. Hauer, Florent Petitprez, Marion Rabant, Paula Vieira Martins, Véronique Baudouin, Yahsou Delmas, Noémie Jourde-Chiche, Alexandre Cez, David Ribes, Sylvie Cloarec, Aude Servais, Mohamad Zaidan, Eric Daugas, Michel Delahousse, Alain Wynckel, Amélie Ryckewaert, Anne Laure Sellier-Leclerc, Olivia Boyer, Eric Thervet, Alexandre Karras, Richard J.H. Smith, Véronique Frémeaux-Bacchi
Publikováno v:
Kidney international. 102(4)
C3 glomerulopathy (C3G) is a rare complement-mediated disease. Specific treatments are not yet available and factors predictive of kidney survival such as age, kidney function and proteinuria are not specific to C3G. The prognostic value of biomarker